EFTA00688932Set 9
2014-04-192p535w
initiated coverage of Foundation
Medicine with a Market Perform rating.
In a report, analyst Amanda Murphy noted Foundation's differentiated platform, an untapped clinical market,
and the company's pharmaceutical
https://www.justice.gov/epstein/files/DataSet%209/EFTA00688932.pdf